AAM
GILD icon

Alphadyne Asset Management’s Gilead Sciences GILD Stock Holding History

Alphadyne Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
94,700
-94,400
-50% -$12.4M 0.11% 162
2026
Q1 		$26.4M Buy
189,100
+83,200
+79% +$11.7M 0.46% 49
2025
Q4 		$13M Buy
+105,900
New +$12.9M 0.3% 47
2023
Q4 		– Sell
-16,100
Closed -$1.21M – 81
2023
Q3 		$1.21M Buy
+16,100
New +$1.24M 0.09% 137

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alphadyne Asset Management's GILD Position: Q2 2026 in Review

Alphadyne Asset Management reduced its Gilead Sciences (GILD) stake by 88% in Q2 2026, selling an estimated $5.23M and leaving 5,436 shares worth $687K. The position accounts for 0.01% of the portfolio, ranked #614.

Alphadyne Asset Management first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.29M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Alphadyne Asset Management held 5,436 shares of Gilead Sciences worth $687K as of Q2 2026.
  • Alphadyne Asset Management sold 39,672 Gilead Sciences shares in Q2 2026, an estimated $5.23M.
  • Gilead Sciences made up 0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #614 holding.
  • Alphadyne Asset Management first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Alphadyne Asset Management's Gilead Sciences position peaked at $6.29M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.